๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› MDS
Clinical trial register · China

MDS Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Suzhou 3 Shanghai 3 Beijing 3 Tianjin 2 Guangzhou 1
Narrow the registerReset
Recruitment status
Phase
Site location
Suzhou3 Shanghai3 Beijing3 Tianjin2 Guangzhou1
All 12 locations
Target enrolment
to

MDS trials in China

12 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS
NCT07575412Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS, Transplantation, Stem Cell
The First Affiliated Hospital of Soochow University
Phase 2
180
Suzhou
2026-06
Not yet open
SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS
NCT07562568Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS, Transplantation, Stem Cell
The First Affiliated Hospital of Soochow University
Phase 2
160
Suzhou
2026-06
Not yet open
Reduced Intensity Conditioning for MDS
NCT07085156MDS
Ruijin Hospital
Phase 2
45
Shanghai
2025-08-01
Recruiting
Molecular Genetics Guide the Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation
NCT06972641AML, MDS
Ruijin Hospital
Phase 2/3
126
Shanghai
2025-06-10
Recruiting
Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy
NCT06895538Leukemia, MDS, Lymphoma
Peking University First Hospital
Phase 2/3
24
Beijing
2025-05-03
Recruiting
A Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological Malignancies
NCT07347171Leukemia, AML, MDS, AML (Acute Myelogenous Leukemia)
Cullgen (Shanghai),Inc
Phase 1
45
Nanchang, Tianjin, Wuhan
2025-04-17
Not yet open
Selinexor Combined With Venetoclax Maintenance Therapy After Allo-HSCT
NCT06765928MDS, AML, Adult
Ruijin Hospital
Phase 2
73
Shanghai
2025-01-01
By invitation
A Multicenter Study on the Treatment of MDS/MPN Overlap Syndrome With AZA or Rux Combined With Selinexor
NCT06664970MDS
Peking Union Medical College Hospital
Phase 2
39
Beijing
2024-11-06
Not yet open
A Study of HS-20106 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes
NCT06594965Myelodysplastic Syndromes, Anemia, MDS, Bone Marrow Disease
Hansoh BioMedical R&D Company
Phase 2
176
Tianjin
2024-10-30
Recruiting
Assessment of Measurable Residual Disease in Allo-HSCT Using Digital Polymerase Chain Reaction
NCT06211166Acute Leukemia, MDS, MDS/MPN, CML
Peking University People's Hospital
Observational
300
Beijing
2024-01-08
Active, closed
A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies
NCT04547049Leukemia, MDS
First Affiliated Hospital of Zhejiang University
Phase 3
232
Changsha, Chongqing, Hangzhou, Nanjing, Ningbo, Suzhou
2020-09-01
Active, closed
Efficacy and Safety of HMAs Combined With Venetoclax Versus HMAs Alone in ND Int-and H-risk MDS or CMML
NCT07318662MDS, CMML
Guangdong Provincial People's Hospital
Observational
224
Guangzhou
2020-01-01
Rows per page Showing 1–12 of 12
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/condition/mds

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 12 of those studies listing the condition MDS.

How many MDS trials are recruiting in China?

4 of the 12 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 5 have not yet opened recruitment, 2 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (MDS), 12 studies
PhaseStudiesRecruitingShare
Phase 26050%
Observational2116.7%
Phase 2/32216.7%
Phase 1118.3%
Phase 3108.3%

Most active sponsors

Lead sponsors with the most studies (MDS)
Lead sponsorStudiesRecruiting
Ruijin Hospital31
The First Affiliated Hospital of Soochow University20
Cullgen (Shanghai),Inc11
First Affiliated Hospital of Zhejiang University10
Guangdong Provincial People's Hospital10
Hansoh BioMedical R&D Company10
Peking Union Medical College Hospital10
Peking University First Hospital11
Peking University People's Hospital11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.